Marker Therapeutics, Inc.·4

Mar 1, 4:48 PM ET

Szymanska Anna 4

4 · Marker Therapeutics, Inc. · Filed Mar 1, 2023

Insider Transaction Report

Form 4
Period: 2023-02-27
Szymanska Anna
Vice President, Quality
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-02-27+29,94729,947 total
    Exercise: $2.14Exp: 2033-02-27Common Stock (29,947 underlying)
Footnotes (1)
  • [F1]This option vests in equal monthly installments over a four year period commencing on March 27, 2023 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION